TSE:4578Pharmaceuticals
Otsuka Holdings (TSE:4578) Lifts Guidance Following Earnings Upgrade and Fair Value Stays In Focus
Otsuka Holdings (TSE:4578) has just lifted its earnings guidance for the first half of 2026, citing stronger business performance, delayed generic competition for key drugs, currency tailwinds, and lower research and development spending.
See our latest analysis for Otsuka Holdings.
Even with the recent guidance upgrade and upcoming H1 2026 earnings call on 31 July, Otsuka Holdings' share price has eased slightly over the past week. However, the 1 month share price return of 4.08% and year to...